Jorizzo J L, Coutts A A, Eady R A, Greaves M W
Eur J Pharmacol. 1983 Jan 28;87(1):67-76. doi: 10.1016/0014-2999(83)90051-1.
The mechanism of cutaneous inflammation caused by substance P in human skin was assessed in five subjects receiving i.d. injections (5-405 pmol) at pH 7.2 as compared to histamine (0.08-1.6 nmol), compound 48/80 (100 ng) and solvent control. Both substance P and histamine produced sigmoid dose-response curves for the following parameters: 1 min and 5 min planimetrically measured areas of erythema, and mean diameter of weal. Substance P pretreatment induced tachyphylaxis, as assessed by standard methods with adequate controls, to both histamine and to substance P and vice versa. Erythema following substance P i.d. was not blocked by a constricting band. Diphenhydramine, and to a lesser extent doxantrazole, (but not cimetidine or indomethacin) when assessed as inhibitors after oral pretreatment, did shift dose response curves for histamine and substance P to the right. Light and electron microscopic assessment of mast cells was compared in substance P and solvent control injected human skin. These results support a possible role for substance P in cutaneous inflammation acting either directly or via histamine release from mast cells.
在5名受试者中评估了pH值为7.2时皮内注射(5 - 405皮摩尔)的P物质在人皮肤中引起皮肤炎症的机制,并与组胺(0.08 - 1.6纳摩尔)、48/80化合物(100纳克)及溶剂对照进行比较。P物质和组胺对以下参数均产生了S形剂量 - 反应曲线:通过平面测量的1分钟和5分钟时的红斑面积,以及风团的平均直径。通过采用适当对照的标准方法评估,P物质预处理对组胺和P物质均诱导了快速耐受,反之亦然。皮内注射P物质后的红斑未被束带阻断。口服预处理后作为抑制剂评估时,苯海拉明以及程度较轻的多克替拉佐(但不是西咪替丁或吲哚美辛)确实将组胺和P物质的剂量反应曲线向右移动。对注射了P物质和溶剂对照的人皮肤中的肥大细胞进行了光镜和电镜评估。这些结果支持P物质在皮肤炎症中可能直接起作用或通过肥大细胞释放组胺起作用。